Vinblastine
- Level
- Commodity
- Parent
- 51111700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111766This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C46H58N4O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V9KLZ54CY, chemically known as 1h-indolizino(8,1-cd)carbazole-5-carboxylic acid, 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2h-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-, methyl ester, (3ar-(3aalpha,4beta,5beta,5abeta,9(3r*,5s*,7r*,9s*),10br*,13aalpha))- but generally known as vinblastine, which bears US NIH Compound Identifier 13342. European Medicines Agency schedules Vinblastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00052MIG. The term VINBLASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules vinblastine in its Anatomical Therapeutic Chemical (ATC) Classification. VINBLASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinblastine under HS 29399900 and SITC 54149. As of Q4 2014, VINBLASTINE remains the US FDA Preferred Term for this commodity. Vinblastine bears US NLM identifiers UMLS ID C0042670 and NCI Concept Code C930. SMILES: O(C1C2(C3N(CCC43C(N(C3C4CC(C(OC)C3)C3(CC4CC(O)(CN(C4)CCC4C3[NH]C3C4CCCC3)CC)C(=O)OC)C)C1(O)C(=O)OC)CC=C2)CC)C(=O)C.
Same parent
Under 51111700 · 67Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.